Loading...
XNAS
APYX
Market cap186mUSD
Jul 09, Last price  
4.46USD
1D
5.94%
1Q
12.63%
Jan 2017
24.23%
Name

Apyx Medical Corp

Chart & Performance

D1W1MN
XNAS:APYX chart
P/E
P/S
3.54
EPS
Div Yield, %
Shrs. gr., 5y
4.27%
Rev. gr., 5y
13.78%
Revenues
53m
+9.86%
26,676,18228,779,15728,096,51026,953,44724,230,00025,411,00027,671,00023,660,00027,681,00029,520,00036,627,00038,883,00016,686,00028,235,00027,711,00048,517,00044,510,00052,349,00048,102,00052,844,000
Net income
-11m
L-52.22%
2,683,2062,400,5911,831,788595,522-1,535,000109,000617,000-4,339,000-17,282,000-5,370,000-3,950,000-5,062,00064,009,000-19,706,000-11,896,000-15,172,000-23,184,000-18,713,000-23,463,000-11,211,000
CFO
-8m
L-55.67%
2,986,2182,041,344742,829-98,332-566,0001,897,000165,000-2,536,000-417,000-5,786,000-2,837,000-3,704,000-21,011,000-18,475,000-16,066,000-10,449,000-20,280,000-5,249,000-18,047,000-8,001,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures. The company’s helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
IPO date
Jul 22, 1983
Employees
276
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT